Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Pachychoroid disease
2018444 citationsChui Ming Gemmy Cheung, Won Ki Lee et al.Eyeprofile →
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
2017214 citationsAdrian Koh, Timothy Y. Y. Lai et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Won Ki Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Ki Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Ki Lee more than expected).
This network shows the impact of papers produced by Won Ki Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Ki Lee. The network helps show where Won Ki Lee may publish in the future.
Co-authorship network of co-authors of Won Ki Lee
This figure shows the co-authorship network connecting the top 25 collaborators of Won Ki Lee.
A scholar is included among the top collaborators of Won Ki Lee based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Won Ki Lee. Won Ki Lee is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lee, Won Ki, Yuichiro Ogura, Tomohiro Iida, et al.. (2017). Efficacy and Safety of Intravitreal Aflibercept in Polypoidal Choroidal Vasculopathy: 12-Month Results of the PLANET Study. Investigative Ophthalmology & Visual Science. 58(8). 1199–1199.3 indexed citations
Lee, Won Ki, et al.. (2006). Effects of Neodymium:YAG Laser and Tissue Plasminogen Activator on Massive Diabetic Premacular Hemorrhage. Journal of the Korean Ophthalmological Society. 47(6). 971–976.
16.
Lee, Won Ki, et al.. (2006). Changes of Network Vessels after Photodynamic Therapy in Polypoidal Choroidal Vasculopathy. Journal of the Korean Ophthalmological Society. 47(11). 1751–1758.1 indexed citations
17.
Lee, Phil Young & Won Ki Lee. (2006). Progression of Retinal Angiomatous Proliferation after Surgical Ablation. Journal of the Korean Ophthalmological Society. 47(9). 1523–1532.1 indexed citations
18.
Lee, Won Ki, et al.. (2004). Photodynamic Therapy of Choroidal Neovasculariation Associated with Large Serous Pigment Epithelial Detachment.. Journal of the Korean Ophthalmological Society. 45(1). 79–86.
19.
Kim, Ki Seok, et al.. (2004). Photodynamic Therapy with Verteporfin in Polypoidal Choroidal Vasculopathy.. Journal of the Korean Ophthalmological Society. 45(2). 216–227.3 indexed citations
20.
Lee, Won Ki, et al.. (2000). A Case of Schwartz's Syndrome.. Journal of the Korean Ophthalmological Society. 41(11). 2514–2519.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.